[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100577605":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":20,"centralContacts":24,"locations":30,"responsibleParty":46,"collaborators":19,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":19,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":19,"enrollmentInfo":57,"targetDuration":19,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":66,"overallStatus":32,"whyStopped":19,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Patients with adenocarcinoma of the pancreas","Patients with adenocarcinoma of the pancreas needing surgical treatment by duodenocephalopancreasect",[12],"Diagnostic Test: Microbiota analysis",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"DIAGNOSTIC_TEST","Microbiota analysis","Upon acquisition of informed consent, fecal, digiunal mucosa, biliary and pancreatic fluid samples will be collected for microbiota analysis",[9],null,[21],{"name":22,"affiliation":5,"role":23},"Ricci Claudio, MD","PRINCIPAL_INVESTIGATOR",[25],{"name":26,"role":27,"phone":28,"phoneExt":19,"email":29},"Claudio Ricci, MD","CONTACT","+39 051 214 3928","claudio.ricci@aosp.bo.it",[31],{"facility":5,"status":32,"city":33,"state":34,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"RECRUITING","Bologna","BO","40138","Italy","IT",{"type":39,"coordinates":40},"Point",[41,42],11.33875,44.49381,{"lat":42,"lon":41},[45],{"name":26,"role":27,"phone":28,"phoneExt":19,"email":29},{"type":47,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100577605","gut-microbiota-analysis-in-patients-undergoing-duodencephalopancreasectomy-for-pancreatic-cancer-100577605",false,"NCT06800469","Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer","Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer (MIcRobiome Analysis in Patients UnderGoing PancrEatico-duodenectomy for Pancreatic Cancer MIRAGE Study)","Inclusion Criteria:\n\n* Age ≥18 years\n* Diagnosis of resectable pancreatic adenocarcinoma with indication for \"upfront\" surgical treatment\n* ASA (American Society of Anesthesiology) score \\\u003C 4\n* Obtaining informed consent\n\nExclusion Criteria:\n\n\\- Pregnant or lactating women","ALL","18 Years",{"count":58,"type":59},30,"ESTIMATED","INTERVENTIONAL",[62],"NA","Pancreatic head cancer represents one of the most frequent malignancies with an incidence of about 13500 new cases each year. The primary objective of the study is to test whether there are bacterial species associated with increased risk of complications in patients with peri-ampullary neoplasia undergoing DCP.",[65],"Pancreatic Cancer, Adult",[67],"pancreatic cancer","2025-01-28",{"date":70,"type":71},"2025-01-30","ACTUAL",{"date":73,"type":71},"2022-07-11",{"date":75,"type":59},"2025-07-01",{"name":5,"class":6},1]